Literature DB >> 345889

A sustained release theophylline preparation: efficacy in childhood asthma with low serum theophylline levels.

G S Rachelefsky, R M Katz, S C Siegel.   

Abstract

In a double-blind, crossover study a sustained release theophylline preparation was found to be effective and safe while controlling the symptoms and improving the measured pulmonary function of 16 chronic childhood asthmatics. Serum theophylline levels between 2.5 and 8.1 microgram/ml were adequate for control of clinical disease.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 345889

Source DB:  PubMed          Journal:  Ann Allergy        ISSN： 0003-4738


  10 in total

Review 1.  Oral xanthines as maintenance treatment for asthma in children.

Authors:  P Seddon; A Bara; F M Ducharme; T J Lasserson
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

2.  Effect of in vitro colchicine and oral theophylline on suppressor cell function of asthmatic patients.

Authors:  D Ilfeld; S Kivity; E Feierman; M Topilsky; O Kuperman
Journal:  Clin Exp Immunol       Date:  1985-08       Impact factor: 4.330

Review 3.  Theophylline.

Authors:  E F Ellis
Journal:  Clin Rev Allergy       Date:  1983-03

4.  Once a day theophylline; serum concentrations.

Authors:  V Nerminathan; S A McKenzie
Journal:  Arch Dis Child       Date:  1984-08       Impact factor: 3.791

5.  Plasma theophylline level and effect on lung function after oral and rectal administration of aminophylline.

Authors:  H Lamont; E Moerman; M Bogaert; M Van Der Straeten; R Pauwels
Journal:  Eur J Clin Pharmacol       Date:  1979-07       Impact factor: 2.953

6.  Slow release theophylline in preschool asthmatics.

Authors:  S P Conway; W T Houlsby
Journal:  Arch Dis Child       Date:  1986-10       Impact factor: 3.791

7.  Protective effect of theophylline on histamine-induced bronchoconstriction in asthmatic children.

Authors:  S Levene; S A McKenzie
Journal:  Br J Clin Pharmacol       Date:  1986-04       Impact factor: 4.335

8.  Serum theophylline levels after use of an anhydrous crystalline theophylline suppository.

Authors:  J Aarbakke; A Høylandskjaer; O N Gamst
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

9.  Combined treatment with sustained-release theophylline and beta2-adrenoceptor-stimulating agents in chronic childhood asthma.

Authors:  G Lönnerholm; T Foucard; B Lindström
Journal:  Br Med J (Clin Res Ed)       Date:  1981-03-28

10.  Control of severe pain with sustained-release morphine tablets v. oral morphine solution.

Authors:  W W Arkinstall; B R Goughnour; J A White; J H Stewart
Journal:  CMAJ       Date:  1989-03-15       Impact factor: 8.262
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.